Flagship Ventures 2007 General Partner LLC, 10% Owner at Eleven Biotherapeutics, Inc. (EBIO), sold 752,202 shares at $3.39 ($2.8M) on 2016-09-20, disclosed to the SEC on 2016-09-21.
Open-market sale of $2.8M EBIO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.31 | 1,939 | $6K | 0.2% |
| 2 | $3.31 | 7,761 | $26K | 0.9% |
| 3 | $3.39 | 10,778 | $37K | 1.3% |
| 4 | $3.39 | 43,139 | $146K | 5.3% |
| 5 | $3.39 | 43,139 | $146K | 5.3% |
| 6 | $3.75 | 64,509 |
| $242K |
| 8.7% |
| 7 | $3.75 | 64,509 | $242K | 8.7% |
| 8 | $3.75 | 258,214 | $968K | 34.8% |
| 9 | $3.75 | 258,214 | $968K | 34.8% |
| Total | $3.70 avg | 752,202 | $2.8M | 100% |
| Filing → |